Back to Search
Start Over
Tildrakizumab as a potential long-term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution
- Source :
- The Australasian journal of dermatologyReferences. 62(2)
- Publication Year :
- 2020
- Subjects :
- Adult
Male
medicine.medical_specialty
business.industry
Tildrakizumab
Racial Groups
MEDLINE
Australia
Dermatology
Middle Aged
medicine.disease
Antibodies, Monoclonal, Humanized
Term (time)
Hidradenitis Suppurativa
Young Adult
Medicine
Humans
Hidradenitis suppurativa
Female
business
Intensive care medicine
Subjects
Details
- ISSN :
- 14400960
- Volume :
- 62
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- The Australasian journal of dermatologyReferences
- Accession number :
- edsair.doi.dedup.....77e817008adb10c10ac25041f183c966